Phosphoinositide 3-kinase inhibitors (PI3K inhibitors)
1-Idelalisib; PIK3CD inhibitor, relapsed or refractory chronic lymphocytic leukemia (CLL), relapsed small lymphocytic lymphoma, follicular lymphoma (FL)
2-Copanlisib; PIK3CA / PIK3CD inhibitör, relapsed follicular lymphoma
3-Duvelisib; PIK3CD / PIK3CG inhibitör, relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), relapsed or refractory follicular lymphoma
4-Alpelisib; PIK3CA inhibitör, HR-positive and HER2/neu-negative breast cancer
5-Umbralisib; PIK3CD and casein kinase CSNK1E inhibitör, relapsed or refractory marginal zone lymphoma (MZL), relapsed or refractory follicular lymphoma
6-Leniolisib; PIK3CD inhibitor, activated PI3K delta syndrome (APDS) / PASLI disease
